Impact of Prognostic Factors on Survival Rates in Patients with Ovarian Carcinoma
| Autor: | Hakan Yetimalar, Burcu Kasap, Sevim Arikan, Sumeyra Tatar, Derya Kilic Sakarya, Askin Yildiz |
|---|---|
| Přispěvatelé: | MÜ |
| Rok vydání: | 2014 |
| Předmět: |
Adult
Oncology Cancer Research medicine.medical_specialty Neoplasm Residual Turkey Epidemiology Population Internal medicine Ovarian carcinoma Cytology medicine Humans Stage (cooking) education Lymph node Survival rate Survival analysis Aged Neoplasm Staging Retrospective Studies Aged 80 and over Ovarian Neoplasms education.field_of_study Prognostic Factors business.industry Public Health Environmental and Occupational Health Middle Aged Prognosis medicine.disease Adenocarcinoma Mucinous Combined Modality Therapy Survival Analysis Cystadenocarcinoma Serous Endometrial Neoplasms Ovarian Cancer Survival Rate medicine.anatomical_structure Lymphatic Metastasis Female Neoplasm Grading business Ovarian cancer Adenocarcinoma Clear Cell Follow-Up Studies |
| Zdroj: | Asian Pacific Journal of Cancer Prevention. 15:6087-6094 |
| ISSN: | 1513-7368 |
| DOI: | 10.7314/apjcp.2014.15.15.6087 |
| Popis: | WOS: 000343723600021 PubMed ID: 25124578 Purpose: The aim of the present study was to invesitigate the impact of significant clinico-pathological prognostic factors on survival rates and to identify factors predictive of poor outcome in patients with ovarian carcinoma. Materials and Methods: A retrospective chart review of 74 women with pathologically proven ovarian carcinoma who were treated between January 2006 and April 2011 was performed. Patients were investigated with respect to survival to find the possible effects of age, gravida, parity, menstruel condition, pre-operative Ca-125, treatment period, cytologic washings, presence of ascites, tumor histology, stage and grade, maximal tumor diameter, adjuvan chemotherapy and cytoreductive success. Also 55 ovarian carcinoma patients were investigated with respect to prognostic factors for early 2-year survival. Results: The two-year survival rate was 69% and the 5-year survival rate was 25.5% for the whole study population. Significant factors for 2-year survival were preoperative CA-125 level, malignant cytology and FIGO clinical stage. Significant factors for 5-year survival were age, preoperative CA-125 level, residual tumor, lymph node metastases, histologic type of tumor, malignant cytology and FIGO clinical stage. Logistic regression revealed that independent prognostic factors of 5-year survival were patient age, lymph node metastasis and malignant cytology. Conclusions: We consider quality registries with prospectively collected data to be one important tool in monitoring treatment effects in population-based cancer research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|